Search clinical trials for: RO5186582

Total 4 results

Hoffmann-La Roche

Terminated

A Study of RO5186582 in Down Syndrome Among Children 6 to 11 Years of Age

Down Syndrome

United States
Hoffmann-La Roche

Terminated

A Study to Evaluate the Safety and Efficacy of Basmisanil in Adults With Severe Motor Impairment Following an Ischemic Stroke

Stroke

Spain, France
Hoffmann-La Roche

Completed

Basmisanil Positron Emission Tomography Study in Japanese Volunteers

Healthy Volunteer

United Kingdom
Hoffmann-La Roche

Completed

A Study of RO5186582 Treatment on Cytochrome P450 (CYP) 3A4 Activity in Healthy Participants

Healthy Volunteer

United Kingdom

3

Subscribe